In this consideration, our study highlights the role of MMP-2 in the regulation of mitochondrial injury mediated by TSPO and VDAC1 in the onset of DCM, thus contributing to the identification of novel potential targets of cardioprotective therapeutic interventions under hyperglycaemia. This evidence concerns the gene MMP2 and Hyperglycemia.